Literature DB >> 17157651

Predicting episodes of poor asthma control in treated patients with asthma.

Karen McCoy1, David M Shade, Charles G Irvin, John G Mastronarde, Nicola A Hanania, Mario Castro, N R Anthonisen.   

Abstract

BACKGROUND: Asthma exacerbations are dangerous, expensive, and difficult to anticipate.
OBJECTIVE: To characterize patients with asthma who had asthma episodes and exacerbations during 4 weeks of observation.
METHODS: A total of 2032 volunteers with asthma (age, 3-64 years; 62% female subjects) were studied over two 2-week intervals after flu vaccine and placebo. Baseline data, including several asthma questionnaires, were analyzed for prediction of subsequent asthma events as recorded on diaries detailing peak flow, medication use, and health care use.
RESULTS: During 28 days of diary collection, 43.2% of participants had at least 1 episode of poor asthma control. Most episodes were characterized by increased use of rescue medications or reductions in peak flow, but nearly 15% of participants had exacerbations characterized by use of systemic corticosteroids, unscheduled health care visits, or both. Episode frequency was highest in children <10 years of age. Additional risk factors were smoking, African American ethnicity, low lung function, and past history of severe asthma. The best predictors were symptom questionnaires, and a simple questionnaire concerning the preceding 2 weeks worked as well as more complex questionnaires or those reflecting longer periods. In regression analyses, questionnaire results, smoking, lung function, ethnicity, and asthma history all were associated with asthma episodes in people older than 10 years, whereas only asthma history was predictive in those <10 years.
CONCLUSION: Symptom questionnaires are predictive of subsequent asthma episodes in people older than age 10 years, but not in younger people. CLINICAL IMPLICATIONS: Simple assessments may be helpful in identifying patients most at risk for future asthma episodes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157651     DOI: 10.1016/j.jaci.2006.09.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

Review 1.  Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control.

Authors:  Urs Frey; Béla Suki
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

2.  Biologic mechanisms of environmental tobacco smoke in children with poorly controlled asthma: results from a multicenter clinical trial.

Authors:  Jason E Lang; Allen J Dozor; Janet T Holbrook; Edward Mougey; Sankaran Krishnan; Shawn Sweeten; Robert A Wise; W Gerald Teague; Christine Y Wei; David Shade; John J Lima
Journal:  J Allergy Clin Immunol Pract       Date:  2013-01-12

Review 3.  What long-term changes in lung function can tell us about asthma control.

Authors:  David A Kaminsky; Charles G Irvin
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

4.  Impact of pharmacist-led educational interventions on asthma control and adherence: single-blind, randomised clinical trial.

Authors:  Kosisochi C Amorha; Mathew J Okonta; Chinwe V Ukwe
Journal:  Int J Clin Pharm       Date:  2020-11-02

5.  Asthma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients.

Authors:  Christian Bime; Christine Y Wei; Janet T Holbrook; Marianna M Sockrider; Dennis A Revicki; Robert A Wise
Journal:  J Allergy Clin Immunol       Date:  2012-09-29       Impact factor: 10.793

Review 6.  Management of critical asthma syndrome during pregnancy.

Authors:  Andrew L Chan; Maya M Juarez; Nisha Gidwani; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

7.  Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma.

Authors:  Leonard B Bacharier; Theresa W Guilbert; Robert S Zeiger; Robert C Strunk; Wayne J Morgan; Robert F Lemanske; Mark Moss; Stanley J Szefler; Marzena Krawiec; Susan Boehmer; David Mauger; Lynn M Taussig; Fernando D Martinez
Journal:  J Allergy Clin Immunol       Date:  2009-02-23       Impact factor: 10.793

8.  Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study.

Authors:  Robert C Strunk; Leonard B Bacharier; Brenda R Phillips; Stanley J Szefler; Robert S Zeiger; Vernon M Chinchilli; Fernando D Martinez; Robert F Lemanske; Lynn M Taussig; David T Mauger; Wayne J Morgan; Christine A Sorkness; Ian M Paul; Theresa Guilbert; Marzena Krawiec; Ronina Covar; Gary Larsen
Journal:  J Allergy Clin Immunol       Date:  2008-10-25       Impact factor: 10.793

9.  Coverage and predictors of adherence to influenza vaccination among Spanish children and adults with asthma.

Authors:  R Jiménez-García; V Hernández-Barrera; P Carrasco-Garrido; A Lopez de Andrés; J de Miguel Diez; A Gil de Miguel
Journal:  Infection       Date:  2009-11-10       Impact factor: 3.553

10.  Poor outcomes and asthma hospitalisations: How important is asthma severity and how do we measure it?

Authors:  T A Omachi
Journal:  Allergol Immunopathol (Madr)       Date:  2009 Sep-Oct       Impact factor: 1.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.